Growth hormone secretagogues (GHS) and growth hormone-releasing hormone (GHRH) analogues are peptides researched for their ability to stimulate endogenous GH release through the pituitary-somatotroph axis in preclinical models.
Key compounds include CJC-1295 (with and without DAC), a long-acting GHRH analogue; Ipamorelin, a selective ghrelin-receptor agonist studied for targeted GH pulse stimulation; GHRP-2 and GHRP-6, growth hormone-releasing peptides with varying selectivity profiles; and Sermorelin, a GHRH(1-29) fragment used in age-related GH decline research.
Also stocked: Hexarelin, MK-677 (Ibutamoren), and Tesamorelin for comprehensive growth hormone pathway research.
For laboratory and research use only. Not for human consumption.
